홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

Di-tert-butyl dicarbonate → HCID 57546011, 화합물

HRID 913947
노트
인쇄 미리보기

반응식

HRID 913947 반응식
[Cl:1][C:2]1[CH:10]=[C:9]([C@H:11]([O:13][CH2:14][C:15]2([C:28]3[CH:33]=[CH:32][C:31]([F:34])=[CH:30][CH:29]=3)[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:27])([CH3:26])[CH3:25])=[O:22])[CH2:17][CH2:16]2)[CH3:12])[C:8]2[C:4](=[CH:5][N:6](COCC[Si](C)(C)C)[N:7]=2)[CH:3]=1.C(OC(OC(C)(C)C)=O)(OC(C)(C)C)=O>FC(F)(F)C(O)=O>[Cl:1][C:2]1[CH:3]=[C:4]2[C:8](=[C:9]([C@H:11]([O:13][CH2:14][C:15]3([C:28]4[CH:29]=[CH:30][C:31]([F:34])=[CH:32][CH:33]=4)[CH2:20][CH2:19][N:18]([C:21]([O:23][C:24]([CH3:26])([CH3:27])[CH3:25])=[O:22])[CH2:17][CH2:16]3)[CH3:12])[CH:10]=1)[NH:7][N:6]=[CH:5]2
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 90495Di-tert-butyl dicarbonateHCID 57546164HCID 57546164, 화합물

생성물 1

HCID 57546011HCID 57546011, 화합물

시약·촉매·용매 1

HCID 6422Trifluoroacetic acid용매

실험 절차

(R)-tert-Butyl 4-((1-(5-chloro-2-((2-(trimethylsilyl)ethoxy)methyl)-2H-indazol-7-yl)ethoxy)methyl)-4-(4-fluorophenyl)piperidine-1-carboxylate (850 mg, 1.375 mmol) was dissolved in trifluoroacetic acid (50% in dichloromethane, 30 mL) and stirred at room temperature for 4 h. The reaction was concentrated, loaded onto a strong cation exchange cartridge (4×2 g cartridges) in methanol, and flushed with several volumes of methanol which were discarded. The product was eluted with 2M ammonia in methanol and concentrated. The crude piperidine was dissolved in dichloromethane (10 mL), and treated with di-tert-butyl dicarbonate(0.48 mL, 2.062 mmol). The reaction was quenched by addition of ethylene diamine (200 mg) in dichloromethane (2 mL). The reaction was concentrated and purified by column chromatography (25%→37% ethyl acetate/n-hexane) to give 650 mg (97%) as a white foam solid. 1H-NMR (CDCl3, 500 MHz) δ 9.66 (bs, 1H), 7.90 (s, 1H), 7.57 (d, J=1.8 Hz, 1H), 7.26 (dd, J=8.9, 5.5 Hz, 2H), 7.07 (dd, J=8.9, 8.6 Hz, 2H), 6.98 (d, J=1.5 Hz, 1H), 4.49 (q, J=6.4 Hz, 1H), 3.74 (m, 2H), 3.38 (d, J=9.2 Hz, 1H), 3.25 (d, J=9.2 Hz, 1H), 3.22 (bs, 2H), 3.05 (m, 1H), 2.97 (m, 1H), 2.26 (m, 1H), 2.06 (m, 1H), 1.84 (m, 1H), 1.73 (m, 1H), 1.43 (m. 12H); 13C NMR (75 MHz, CDCl3) δ ppm 171.0, 161.5 (d, J=247 Hz), 154.8, 137.9, 137.8, 135.4, 133.7, 128.5 (d, J=7.5 Hz), 127.3, 125.9, 124.6, 124.0, 118.9, 115.5 (d, J=21 Hz), 79.4, 78.5, 78.1, 60.3, 41.0, 39.8 (br), 32.3, 32.0, 28.3, 22.0, 20.9, 14.1. Mass spec.: 488.17 (MH)+.

후처리

  1. concentrationThe reaction was concentrated
  2. customflushed with several volumes of methanol which
  3. washThe product was eluted with 2M ammonia in methanol
  4. concentrationconcentrated
  5. dissolutionThe crude piperidine was dissolved in dichloromethane (10 mL)
  6. customThe reaction was quenched by addition of ethylene diamine (200 mg) in dichloromethane (2 mL)
  7. concentrationThe reaction was concentrated
  8. custompurified by column chromatography (25%→37% ethyl acetate/n-hexane)
  9. customto give 650 mg (97%) as a white foam solid

출처 및 근거

ORD 기록
ord-8c71bd420e6d48c39398a4197e58bfa0
출처 데이터셋
uspto-grants-2011_09
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08026257B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트